Breaking AI & Tech News Analyzed

The 'Non-Earner' Trap in Clinical PlacementsRoberta Leem-Bruggen’s letter highlights a critical flaw in the UK’s social safety net for parents in higher education. The 'nerd tax' creates a financial trap where students working full-time hours in clinical placements lose eligibility for childcare support, forcing them to repay thousands of pounds.Leem-Bruggen recounts her experience as a single parent on an NHS placement. Despite working over 40 hours a week, the Department for Work and Pensions (DWP) classified her as a 'non-earner' because she wasn't receiving a salary. This resulted in a retroactive demand to repay nearly £10,000 in childcare support, despite the initial assessment confirming her eligibility.The Economic Cost of Academic ProgressionThe case illustrates a severe financial bottleneck for postgraduate students who are also primary caregivers.Repayment Burden: Students can face retroactive repayments of up to £10,000 for a single academic year.Time Commitment: Clinical placements often require over 40 hours of unpaid work per week, effectively mimicking full-time employment.Current Status: The author is now a PhD student with three children, relying entirely on a stipend and a partner's income, highlighting the precarious nature of funding for families.Systemic Exclusion of Parental FiguresThis issue extends beyond a single case; it signals a systemic failure to support the demographic of parents pursuing postgraduate education. The current framework assumes that higher education is a luxury reserved for those without dependents or financial backing. This creates a 'binary choice' for parents: sacrifice academic advancement or rely on family wealth, effectively widening the gap in social mobility.Policy Reform or Continued Exclusion?As the cost of living rises and the demand for skilled professionals in sectors like healthcare grows, the exclusion of parents from childcare support could lead to a shortage of qualified staff. Future policy reforms will likely need to address the definition of 'earning' to include stipends and clinical placements, or risk losing a generation of potential experts in critical fields.

The Lead Public-sector pension schemes in the UK have been a topic of discussion lately, particularly regarding their funding. A recent letter from Prof Stephen Caddick highlighted the £1tn in liabilities for public defined-benefit (DB) pension schemes, sparking debate about the fairness and affordability of these schemes. The Event Details There are five large 'unfunded' public-sector pension schemes in the UK: NHS, teachers, civil servants, police, and army. Employers, and ultimately taxpayers, contribute a significant amount to these schemes. However, without a decent pension scheme, these sectors would likely require higher levels of pay to recruit and retain staff, which would also fall on taxpayers. The Data Analysis The £1tn liability figure mentioned is misleading, as it estimates the money the government would have to pay out to cover pensions if there were no income coming from workers and employers. This figure is likely to be around £1.3tn. In contrast, other DB schemes, both public and private, are 'funded' through investment in the stock market. The Impact Analysis Public-sector workers choose their jobs based on the total package offered, including a good pension and strong benefits. These benefits allow the state to attract people who could earn considerably more in the private sector. The current system effectively defers the welfare bill, as generous public-sector pensions are a way of deferring costs to future administrations. The Prediction It would be more honest to raise pay so that staff could fund pensions and benefits themselves. However, no government is likely to do this, as it would create a problem today in exchange for solving one that lands on a future administration.

Review Calls for Ban on Political Badges in NHSA government‑appointed anti‑Semitism review recommends that NHS staff be barred from wearing any political badges, including pro‑Palestinian symbols, on their uniforms.John Mann’s Anti‑Semitism Review Targets Uniform PoliticsThe review, authored by John Mann, was commissioned after the October 2023 Manchester synagogue attack. Mann argues that visible political statements, such as “I support Palestine” or “I support Israel,” distract from patient care and could undermine trust.Ban on all political badges (Palestinian, Israeli, party, football)Staff required to remove existing badges during work hoursHospitals become “first line of defence against racism and discrimination”No Quantitative Data Reported in the ReviewThe document does not provide statistics on badge prevalence or measured impact on patient outcomes.Implications for NHS Neutrality and Patient TrustHealth Minister James Murray described the recommendations as “robust and practical,” suggesting imminent policy changes. If adopted, the NHS could set a precedent for stricter political neutrality in public services, potentially influencing other sectors.Outlook: Enforcement, Legal Challenges and Wider Political DebateImplementation will require clear guidance, monitoring mechanisms, and may face legal challenges from civil‑rights groups. The move also feeds into broader UK debates over free expression versus anti‑discrimination safeguards.

Breakthrough Cancer Drug Reveals Hidden TumorsA smart drug that stops cancer cells "hiding" from treatment can shrink tumours by at least 30% in six of the world's most common forms of the disease, according to early trial results. While immunotherapy treatments have improved survival rates for many patients, their effectiveness can stall or fail when tumour cells hide and then spread.How the Smart Drug WorksResearchers in Oxford have developed a drug designed to stop cancer cells concealing themselves from the immune system, allowing immunotherapy treatments to identify and destroy them. In a trial spanning the UK, France, Spain and Australia, 83 patients with cervical, bladder, liver, bowel, lung or head and neck cancers were given the experimental drug, GRWD5769, alongside the immunotherapy treatment cemiplimab.The smart drug was able to remove "invisibility cloaks" from tumour cells, exposing them to the parts of the immune system that attack infections and diseases. This allowed the cemiplimab immunotherapy to pinpoint and destroy the cancer.Trial Results Across Cancer TypesResearchers, led by the Christie NHS foundation trust in Manchester, England, found that tumours shrank in 26 patients. Of those, 15 experienced tumour reductions of at least 30%. All participants had previously failed to respond to treatment, and most had no options left when they joined the study.GRWD5769 was shown to shrink tumours in all six cancer types included in the trial. The drug halted progression of the disease for at least six months in 18% of cervical cancer patients, 32% of liver cancer patients, 36% of bladder cancer patients, 38% of those with neck and head cancer, and more than half of bowel (51%) and lung (55%) cancer patients.Significance for Cancer TreatmentImmunotherapy enlists T-cells – immune system cells that attack infections and diseases – to hunt and destroy cancer. Although it has revolutionised cancer care, it fails in about two-thirds of patients. This is because immunotherapy struggles when tumours hide from the immune system.Tumours can evade the immune system by manipulating an enzyme called ERAP1 (endoplasmic reticulum aminopeptidase 1). By altering this enzyme, cancer cells can hide from a patient's T-cells. GRWD5769 solves this problem by inhibiting ERAP1, which removes cancer's invisibility cloak and makes tumour cells visible to T-cells that could not previously find them.Future Outlook for Cancer TreatmentThe findings were presented at the American Society of Clinical Oncology's annual meeting in Chicago, the world's largest cancer conference. Prof Fiona Thistlethwaite, the principal investigator, noted: "For a drug that is given as a tablet, this is very impressive. It's early days, and we need further studies, but this is a new drug with a new mechanism that clearly helps immunotherapy perform more effectively."The tablets, which were developed by Oxford-based Greywolf Therapeutics and were tolerated well by patients. The trial remains ongoing, with a larger study planned. Cancer Research UK's research information lead, Dr Samuel Godfrey, noted: "Immunotherapy has transformed treatment for some cancers but it doesn't yet work for everyone. This trial seems to show how this new drug could make immunotherapy more effective, including in some cases where immunotherapy had previously failed."

The Poll Shows Cost of Living Dominates Voter ConcernsVoters in Makerfield told researchers that the cost of living crisis, fading high streets and strained public services are the issues that will decide how they vote in the upcoming by‑election on 18 June. A strong undercurrent of distrust toward politicians also emerged.Focus‑Group Findings on Local PrioritiesThe research was commissioned by 38 Degrees and carried out by JL Partners. It involved 112 residents who answered six open‑ended questions about the changes they want to see, the tone they expect from their MP and the messages they would send to a new representative.More than one‑third of participants spontaneously mentioned the cost of living, citing household bills, food, fuel, council tax and affordable housing.High‑street vitality, road maintenance and NHS access were each highlighted by roughly three in ten respondents.Immigration featured for about one in eight voters, especially among those leaning toward Reform UK.Voters called for “boldness” and honesty from politicians, expressing frustration with a system they view as “broken”.Voting Intentions and Party Support BreakdownThe same focus‑group revealed a near‑even split in party preference:31.2% intend to vote Labour30.4% intend to vote Reform UK10.7% each for the Greens and the Conservatives3.6% for the Liberal Democrats13.4% for other partiesThese figures mirror broader polling that shows Greater Manchester mayor Andy Burnham holding a narrow lead over his Reform challenger.Implications for the Upcoming Makerfield By‑ElectionThe data suggests that any candidate who can credibly address the cost‑of‑living squeeze and revive the high street will gain a decisive edge. Burnham is positioned as a “snapshot of the country in miniature”, but his perceived use of the seat as a stepping‑stone could alienate voters demanding local commitment.Both Labour and Reform UK must grapple with the dual demand for tangible economic relief and a trustworthy, locally‑focused MP.What the Results Signal for Greater Manchester PoliticsShould the Makerfield contest remain as close as the focus‑group indicates, the constituency could become a bellwether for how cost‑of‑living anxiety shapes future elections across the region. Parties that combine fiscal relief proposals with a clear, honest narrative are likely to capture the “real people” vote that voters say they represent.

MPs Hear Graduates Labeled as ‘Cash Cows’ in Treasury Committee InquiryStudent representatives and policy experts told the Treasury select committee that the current student‑loan framework is being used to generate revenue for older‑age benefits, effectively turning graduates into a fiscal resource for the state pension triple‑lock.Financial Toll: £15bn Triple‑Lock Cost and Rising Loan InterestThe committee heard that the triple‑lock, which guarantees the UK state pension rises by the highest of three measures, will cost the government £15 billion a year by 2030. At the same time, the government froze the plan‑2 repayment threshold at £29,385 until 2030, meaning graduates must repay 9 % of earnings above that level.Average graduate loan balance: >£40,000Interest added to a 33‑year‑old NHS doctor’s loan: £38,000Projected repayment multiple: 2 – 2.5 × original loan amountIntergenerational Fiscal Strain and Political BacklashExperts likened the situation to the car‑finance and PPI mis‑selling scandals, arguing that retroactive changes to loan terms breach basic consumer‑protection principles. Philip Augar, who led the 2019 higher‑education funding review, called the practice “almost sneaky” and urged a duty of care comparable to that expected of financial services firms.The narrative of graduates funding older generations has ignited public anger and heightened pressure on the Labour government, led by Rachel Reeves, to address what is being framed as an intergenerational crisis.Potential Reforms and the Road Ahead for UK Student LoansGovernment spokespeople point to recent measures: raising the repayment threshold for the first time since 2021, capping maximum interest rates, and re‑introducing targeted maintenance grants. However, critics argue these steps are insufficient and call for:A comprehensive review of loan interest accrual methodsTransparent communication of loan terms to borrowersDecoupling graduate loan revenue from pension financingFuture parliamentary hearings and possible FCA involvement could reshape the student‑loan landscape, aiming to balance fiscal sustainability with fairness for the next generation of graduates.

Lead: A Decade‑Long Warning from BrexitThe Guardian’s Richard Partington argues that the ten‑year legacy of Brexit is a stark reminder that “easy solutions” to deep‑seated issues rarely work. Citing economists such as Nick Bloom and former minister Alan Milburn, the piece highlights the persistent economic drag and the political complexity of any re‑entry plan.Brexit’s Ten‑Year Economic TollTen years after the binary referendum, the UK’s departure from the EU has proven far from the promised panacea. The lack of a clear, implementable vision left businesses in limbo, freezing investment and stalling trade.Quantifying the GDP, Investment, Employment and Productivity GapsGDP per head: up to 8% lower than a remain scenario.Business investment: roughly 18% lower than it would have been.Employment: about 4% lower than under remain.Productivity: down up to 4% relative to a stay‑in‑EU trajectory.These figures come from a paper by Nick Bloom for the US National Bureau of Economic Research, reinforcing the scale of the economic setback.Why the Brexit Experiment Undermines UK Growth ProspectsThe fallout stems from a coalition of libertarian Atlanticists and anti‑globalist voters whose expectations diverged sharply. While the former envisioned a “Singapore‑on‑Thames” low‑tax model, the latter demanded higher public spending, such as the £350 m a week for the NHS. The clash made coherent policy impossible, leading to regulatory duplication, trade friction, and a loss of confidence among investors.Geopolitical shifts—U.S. protectionism under Donald Trump, rising tensions with China, and Middle‑East conflicts—have further exposed the fragility of the UK’s trade‑first strategy, prompting renewed calls for closer EU ties.What the Next Decade Could Hold for Britain’s EU RelationsExperts like former BoE policymaker Danny Blanchflower caution that any move to re‑join the EU would be “far too simplistic” without a detailed, negotiated framework covering regulations, standards, and market access. The political landscape, still influenced by figures such as Nigel Farage and the potential rise of a Reform UK government, adds uncertainty that could keep investment muted.In the absence of a clear, expert‑driven roadmap, the UK risks prolonging the economic drag while grappling with other structural challenges, notably a looming youth unemployment crisis projected to exceed 1 million by the early 2030s.

A Critical Portrait of George MichaelIn 1998, George Michael was arrested for public lewdness in an LA lavatory, an incident that finally led the singer to publicly come out. The following day, Sathnam Sanghera found himself unable to leave his room at university: the doorway had been mockingly plastered with tabloid newspaper headlines – "ZIP ME UP BEFORE YOU GO-GO!" – by fellow students aware of his longstanding fandom. As a writer, Sanghera is best known for a series of award-winning books on the British empire, which he calls his "specialist subject". Judging by Tonight the Music Seems So Loud – not a biography so much as a miscellany, a set of themed essays that tend to digress in all kinds of intriguing directions – the life and work of one Georgios Panayiotou runs imperialism and its legacy a very close second.The Complex Legacy of a Pop IconIt is an unashamedly partisan book, although not an uncritical one. Sanghera is as alive to Michael's personal and professional failings (whether the naffness of some of his early work as one half of Wham! or his high-handed treatment of the duo's other half, Andrew Ridgeley) as he is in love with his artistic triumphs. These, of course, range from Careless Whisper and Wham!'s annually inescapable Last Christmas to the 1996 solo masterpiece Older, a peculiar and peculiarly effective cocktail of raw grief at the Aids-related death of his lover Anselmo Feleppa and unrepentant horniness.The Evolution of Critical ReceptionSanghera's love for his subject is evidently sharpened by the opprobrium of others. Indeed if the book has a flaw, it's that the author is old enough to remember an era when George Michael was deemed insufferably uncool by some arbiters of taste (incredibly, when Wham! performed at a 1984 benefit show for striking miners, the only mainstream pop act to show support for the cause, they were received stone-faced by the audience and savaged by the music press for their trouble), and thus has a tendency to underestimate how much both he and his music have been critically re-evaluated in the 21st century.The Artistic Journey of George MichaelHe says one of the spurs to write the book was his belief that "most truly popular music is not generally deemed worthy of serious analysis and George Michael's music most certainly is not". That might have been true once, but certainly not of late: when he died, this newspaper alone ran six features by critics analysing different aspects of his music. "He sang so exquisitely about the marrow of life, about the vital, corporeal things", wrote one, which definitely doesn't amount to taking George Michael insufficiently seriously.double quotation markEven as he skinned up in front of journalists and discussed his drug use and sex life, he was concealing the extent of the addictions that eventually killed himFamily Background and Cultural IdentitySanghera is very good on the climate of homophobia in the 80s, which might have given any gay public figure serious qualms about coming out, and fascinating on Michael's family background: how growing up embedded in north London's Greek Cypriot community impacted on everything from Wham!'s image – not camp, Sanghera suggests, but "the vision of two children of immigrants imagining a kind of glamour they had not actually experienced before" – to his work ethic and control freakery. His dad made good in England by working exceptionally hard, running such a tight ship at his restaurant that he summarily fired his only son for messing up the drinks orders. The fact that the same son went on to hire 12 different saxophonists before finding one that could play the solo on Careless Whisper to his satisfaction doesn't come as a huge surprise.The Perfectionist and Contradictory ArtistThis my-way-or-the-highway perfectionism could yield hugely impressive results – Careless Whisper's sax hook may well be the most famous in pop history – but it could equally lead to intransigence and self-sabotage. Michael worked incredibly hard to transform himself from a member of a teen pop band into a more adult-facing solo artist, but having sold a staggering 25m copies of his 1987 solo debut Faith, he refused to promote its follow-up Listen Without Prejudice Vol. 1, or even make videos for its singles: a better album than its predecessor, it achieved only a fraction of its sales as a result. It was evidence of a deeply contradictory nature that occasionally has Sanghera throwing up his hands in bewilderment.The Public and Private Faces of George MichaelMichael was a polymath, keen to be duly credited as the sole singer, writer, producer and musician on a succession of tracks, but also had a weird habit of talking down his abilities, claiming he couldn't play instruments he was perfectly capable of playing. He was a Stakhanovite who increasingly worked at an agonisingly glacial pace, endlessly fussing over details, a state of affairs not much helped by his gargantuan appetite for marijuana: coupled with bouts of writers' block, it meant he released only six albums of original material in a career that lasted 34 years. He was a Labour voter, booster of the NHS and famously generous philanthropist who also engaged in tax avoidance. After being publicly outed, he became a notoriously frank interviewee ("as if nothing can embarrass him anymore" the Guardian's Simon Hattenstone suggested when he met him in 2009). But even as he skinned up in front of journalists and freely discussed his drug use and sex life, he was concealing the extent of the addictions that eventually killed him.The Decline and Final YearsMichael emerges as a messy, unpredictable but ultimately hugely likable figure, which makes the essay about his demise particularly tough reading. Listed starkly on the page, the facts of his final 10 years make it obvious that he was a deeply unwell man whose life had spun wildly out of control: drug busts, medical emergencies, visits to rehab, rumours of breakdowns and suicide bids and seven incidents in which he either crashed his car or was found comatose at the wheel.The Professional Mask of Personal StruggleThat it somehow didn't appear obvious at the time – that his death at 53 felt like a shock rather than a grim inevitability – seems remarkable, but as Sanghera points out, Michael's professionalism did a lot to paper over the cracks. He was always available to the media and always smart, funny and self-effacing: to use a modern turn of phrase, he controlled the narrative. He was punctilious about his appearance – the star certainly never looked like an ailing drug addict – and unfailingly superb onstage.The Hidden Realities Behind the FameBehind the scenes, it was a different story. He struggled to make new music: at one juncture he booked six months of recording sessions but never turned up to the studio once. His once-acute commercial instincts seemed to desert him: even Sanghera can't muster much enthusiasm for the handful of still-unreleased songs he completed in his final years. He cut off close friends and family who tried to intervene. No one who knew him seems to have been particularly surprised by his death: the list of adjectives used to describe him on his official website now includes not just "icon" "legend" "soul singer" and "philanthropist" but "addict" "repeat offender" and "depressive".An Imagined Alternative LegacyAs the book draws to a close, Sanghera offers a heartbreaking alternative history. He imagines Michael conquering his addictions, coming to a complete accommodation with his musical past (to the end of his life, he was dismissive of Wham!, describing their oeuvre as an exercise in "ignoring my own intelligence" and declining to play most of their hits live) and headlining Glastonbury, "getting pleasure from the audience reaction to Club Tropicana".The Enduring Power of George Michael's MusicIt's affecting because you can imagine it so vividly: the endless succession of hits that anyone with even a passing interest in pop music knows, the pandemonium in the crowd when he breaks out Careless Whisper, the encore of Freedom '90. You don't have to be a fan on Sanghera's level to understand what a triumph it would have been. Tonight the Music Seems So Loud: The Meaning of George Michael by Sathnam Sanghera is published by Picador (£22). To support the Guardian, buy a copy at guardianbookshop.com. Delivery charges may apply.

The explosive growth of Palantir’s AI‑driven platformSince its 2003 launch, the company founded by Peter Thiel has leveraged AI‑powered software to turn massive, complex data sets into actionable insights for governments and corporations. Its client roster now spans the NHS, the US military, ICE, and the Israeli defence forces, underpinning a valuation that has climbed to roughly $375 bn after a 1,500% stock surge since the 2020 IPO.Valuation, contracts and the £600 m UK footprint£600 m in contracts with the UK Ministry of Defence, several police forces and the NHS.£50 m Metropolitan Police deal blocked by Mayor Sadiq Khan in May 2026.Projected UK revenue growth of 30% YoY, according to internal estimates.Political and civil‑society pushback in BritainOpposition has coalesced around concerns that a US‑controlled firm is embedding itself in sovereign infrastructure. A petition signed by nearly a quarter‑million people called for the termination of all Palantir contracts, while MPs such as Martin Wrigley warned the Financial Conduct Authority’s partnership could expose sensitive data to US authorities.Data‑privacy concerns and the NHS contract controversyInvestigations revealed that Palantir gained access to un‑anonymised patient records under a £330 m NHS contract, prompting health‑justice charity Medact to warn of “data‑driven abuses of state power” and potential ICE‑style raids. Palantir maintains that any use outside client instructions would breach contract and be illegal.Future outlook: regulatory risk and competitive pressureShort‑seller Michael Burry has flagged the stock as overvalued, citing vulnerability to emerging rivals offering comparable analytics without the geopolitical baggage. If UK regulators tighten data‑sharing rules or if public procurement policies shift toward domestic providers, Palantir’s UK pipeline could face material setbacks.